Fingerprint
Dive into the research topics where James P Allison is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Local Treg cell loss reprogrammes systemic antitumour immunity without breaking tolerance
Chaib, M. & Allison, J. P., Jan 2026, In: Nature Reviews Immunology. 26, 1, p. 5 1 p.Research output: Contribution to journal › Comment/debate › peer-review
-
Anti-CTLA-4 generates greater memory response than anti-PD-1 via TCF-1
Mok, S., Liu, H., Çobanoğlu, D. A., Anang, N. A. A. S., Mancuso, J. J., Wherry, E. J. & Allison, J. P., Jan 14 2025, In: Proceedings of the National Academy of Sciences of the United States of America. 122, 2, e2418985122.Research output: Contribution to journal › Article › peer-review
Open Access12 Link opens in a new tab Scopus citations -
Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy
Baruch, E. N., Gleber-Netto, F. O., Nagarajan, P., Rao, X., Akhter, S., Eichwald, T., Xie, T., Balood, M., Adewale, A., Naara, S., Sathishkumar, H. N., Islam, S., McCarthy, W., Mattson, B. J., Ferrarotto, R., Wong, M. K., Davies, M. A., Jindal, S., Basu, S. & Roversi, K. & 41 others, , Aug 20 2025, (E-pub ahead of print) In: Nature.Research output: Contribution to journal › Article › peer-review
27 Link opens in a new tab Scopus citations -
Correction: Editor’s Note: Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade (Cancer Discov, (2016), 6, (827–837))
Chen, P. L., Roh, W., Reuben, A., Cooper, Z. A., Spencer, C. N., Prieto, P. A., Miller, J. P., Bassett, R. L., Gopalakrishnan, V., Wani, K., De Macedo, M. P., Austin-Breneman, J. L., Jiang, H., Chang, Q., Reddy, S. M., Chen, W. S., Tetzlaff, M. T., Broaddus, R. J., Davies, M. A. & Gershenwald, J. E. & 24 others, , Dec 1 2025, In: Cancer discovery. 15, 12, p. 2574 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Inhibition of CD38 enzyme activity on engrafted human immune cells enhances NAD+ metabolism and inhibits inflammation in an in-vivo model of xeno-GvHD
Ahmil-Boiteau, G., Dalvi, P., Dang, K., Ugamraj, H. S., Castello, G., Allison, J., Schellenberger, U., Buelow, R., Iyer, S., Buelow, B., Chini, E., Blazar, B., Cuturi, M. C., van Schooten, W. & Ouisse, L. H., 2025, In: Frontiers in immunology. 16, 1640611.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations